SCHEMBL17080409

SCHEMBL17080409

Cc1cc(-c2ncc(-c3cccnc3)cc2S(C)(=O)=O)cnc1-c1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.50
PTGS1 P23219 3/20 0.50
CYP2A6 P11509 5/20 0.49
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
PDGFRB P09619 2/20 0.40
PDGFRA P16234 2/20 0.40
EGFR P00533 1/20 0.40
ALK Q9UM73 1/20 0.40
CYP11B2 P19099 2/20 0.39
CYP11B1 P15538 1/20 0.39
NTRK1 P04629 1/20 0.39
MET P08581 1/20 0.39
CYP3A4 P08684 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18624987 0.86 CYP2A6 (0.64) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL18624985 0.86 CYP2A6 (0.64) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL17060239 0.86 CYP2A6 (0.64) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL18624986 0.81 CYP2A6 (0.56) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL18624988 0.77 CYP2A6 (0.55) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL17060220 0.75 CYP2A6 (0.57) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL17060233 0.72 SLC2A1 (0.53) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL17060302 0.72 CYP2A6 (0.46) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL29695665 0.72 CYP2A6 (0.46) PTGS2PTGS1CYP2A6MKNK1MKNK2
SCHEMBL17060301 0.72 CYP2A6 (0.46) PTGS2PTGS1CYP2A6MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3114119-A1 MCL-1 MODULATING COMPOUNDS FOR CANCER TREATMENT Centre de Lutte Contre le Cancer Francois Baclesse (FR) 2017-01-11 EP disclosed
WO-2015132727-A1 MCL-1 MODULATING COMPOUNDS FOR CANCER TREATMENT CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE (FR) 2015-09-11 WO disclosed